SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Schrodinger, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.12+0.52 (+2.30%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
Schrodinger statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Schrodinger | Industry median |
|---|---|---|
| Market Cap | $1.73B | $166.30M |
| Enterprise Value | $1.32B | $88.19M |
| PS Ratio | 6.68 | 3.65 |
| PB Ratio | 5.26 | 2.03 |
| P/TBV Ratio | 5.34 | 2.29 |
Enterprise value
| Measure | Schrodinger | Industry median |
|---|---|---|
| EV / Sales | 5.08 | 2.51 |
Income (trailing twelve months)
| Measure | Schrodinger | Industry median |
|---|---|---|
| Revenue | $259.04M | $58.34M |
| Gross Profit | $147.31M | $105.94M |
| Operating Income | -$153.45M | -$21.40M |
| Pretax Income | -$51.93M | -$14.34M |
| Net Income | -$54.34M | -$22.46M |
| EBITDA | -$147.58M | -$16.91M |
| EPS (Diluted) | -$0.74 | -$0.83 |
Margins
| Measure | Schrodinger | Industry median |
|---|---|---|
| Gross Margin | 56.9% | 52.9% |
| Operating Margin | -59.2% | -44.0% |
| Pretax Margin | -20.0% | -13.3% |
| Profit Margin | -21.0% | -40.2% |
| EBITDA Margin | -57.0% | -30.2% |
| FCF Margin | -50.3% | -9.27% |
Returns
| Measure | Schrodinger | Industry median |
|---|---|---|
| Return on Equity (ROE) | -16.2% | -53.2% |
| Return on Assets (ROA) | -8.18% | -40.9% |
| Return on Capital Employed (ROCE) | -32.9% | -38.1% |
Growth
| Measure | Schrodinger | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 8.88% | 5.96% |
| FCF Growth (YoY) | -634.5% | 2.34% |
| Revenue Growth (3Y CAGR) | 12.2% | 2.25% |
| Revenue Growth (5Y CAGR) | 18.8% | 6.48% |
Balance sheet
| Measure | Schrodinger | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $413.74M | $61.43M |
| Net Cash (Debt) | $413.74M | $15.35M |
| Net Cash Per Share | $5.53 | $0.66 |
| Equity (Book Value) | $328.96M | $49.09M |
| Book Value Per Share | $4.40 | $1.37 |
| Tangible Book Value | $324.17M | $23.52M |
| Working Capital | $296.63M | $76.81M |
Financial position
| Measure | Schrodinger | Industry median |
|---|---|---|
| Current Ratio | 2.71 | 3.34 |
| Quick Ratio | 2.50 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Schrodinger | Industry median |
|---|---|---|
| Operating Cash Flow | -$126.87M | -$12.35M |
| Capital Expenditures | -$3.40M | -$1.08M |
| Free Cash Flow | -$130.27M | -$20.22M |
| FCF Per Share | -$1.74 | -$0.42 |
Efficiency
| Measure | Schrodinger | Industry median |
|---|---|---|
| Asset Turnover | 0.39 | 0.39 |
| Revenue Per Employee | $304.75K | $404.87K |
| Profits Per Employee | -$63.92K | -$703.34K |
| Employee Count | 850 | 74 |
Dividends and yields
| Measure | Schrodinger | Industry median |
|---|---|---|
| Earnings Yield | -3.14% | -23.3% |
| FCF Yield | -7.53% | -8.72% |
Shares
| Measure | Schrodinger | Industry median |
|---|---|---|
| Shares Outstanding | 74,805,600 | 58,127,000 |
| Shares Change (YoY) | 1.67% | 10.9% |
| Float | 72,385,400 | 49,136,700 |
| Shares Held by Insiders | 3.24% | 11.6% |
| Shares Held by Institutions | 86.5% | 59.4% |
Taxes
| Measure | Schrodinger | Industry median |
|---|---|---|
| Income Tax | $2.40M | $79.87K |
Scores
| Measure | Schrodinger | Industry median |
|---|---|---|
| Altman Z-Score | 2.01 | -0.22 |
| Piotroski F-Score | 5 | 4 |
| Beneish M-Score | -3.51 | -2.62 |
Calculated by StockData from Schrodinger's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.